Thermalin Diabetes' Unattributed VC Round

Thermalin Diabetes raised a round of funding on October 26, 2010. Investors include JumpStart.

Thermalin is pursuing promising product profiles that will improve insulin therapy for specific classes of patients and enable new delivery technologies. These include: Ultra-concentrated (U500) insul…

Articles about Thermalin Diabetes' Unattributed VC Round: